Repurposing of thalidomide and its derivatives for the treatment of SARS-coV-2 infections: Hints on molecular action.

Lakshmikirupa Sundaresan Suvendu GiriHimanshi SinghSuvro Chatterjee

Published in: British journal of clinical pharmacology (2021)

The present study indicates thalidomide analogues as a better fit for treating severe cases of novel viral infections, healing the damaged network by compensating the impairment caused by the COVID-19.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
early onset
molecular docking
structure activity relationship
drug induced